These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 32368501)

  • 1. Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners.
    Peabody J; Paculdo D; Acelajado MC; Burgon T; Dahlen JR
    J Clin Transl Endocrinol; 2020 Jun; 20():100224. PubMed ID: 32368501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,5-anhydroglucitol as a useful marker for assessing short-term glycemic excursions in type 1 diabetes.
    Seok H; Huh JH; Kim HM; Lee BW; Kang ES; Lee HC; Cha BS
    Diabetes Metab J; 2015 Apr; 39(2):164-70. PubMed ID: 25922811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of serum 1,5-anhydroglucitol measurements in childhood obesity in the continuum of diabetes.
    Yoo HY; Kwak BO; Son JS; Kim KS; Chung S
    Ann Pediatr Endocrinol Metab; 2015 Dec; 20(4):192-7. PubMed ID: 26817006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance.
    Pramodkumar TA; Jayashri R; Gokulakrishnan K; Velmurugan K; Pradeepa R; Anjana RM; Mohan V
    Indian J Endocrinol Metab; 2016; 20(5):690-695. PubMed ID: 27730082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,5-Anhydroglucitol in diabetes mellitus.
    Kim WJ; Park CY
    Endocrine; 2013 Feb; 43(1):33-40. PubMed ID: 22847316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of glycemic markers HbA1c, 1,5-anhydroglucitol and glycated albumin in evaluating gestational diabetes mellitus.
    Saglam B; Uysal S; Sozdinler S; Dogan OE; Onvural B
    Ther Adv Endocrinol Metab; 2017 Dec; 8(12):161-167. PubMed ID: 29238514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker.
    Buse JB; Freeman JL; Edelman SV; Jovanovic L; McGill JB
    Diabetes Technol Ther; 2003; 5(3):355-63. PubMed ID: 12828817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of different glycemic control metrics for optimizing management of diabetes.
    Kohnert KD; Heinke P; Vogt L; Salzsieder E
    World J Diabetes; 2015 Feb; 6(1):17-29. PubMed ID: 25685275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural interventions for type 2 diabetes: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(21):1-45. PubMed ID: 23074526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol.
    Lee JE
    Ann Pediatr Endocrinol Metab; 2015 Jun; 20(2):74-8. PubMed ID: 26191510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.
    Nicolucci A; Ceriello A; Di Bartolo P; Corcos A; Orsini Federici M
    Diabetes Ther; 2020 Mar; 11(3):573-584. PubMed ID: 31873857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Process- and Outcome-Based Financial Incentives to Improve Self-Management and Glycemic Control in People with Type 2 Diabetes in Singapore: A Randomized Controlled Trial.
    Bilger M; Shah M; Tan NC; Tan CYL; Bundoc FG; Bairavi J; Finkelstein EA
    Patient; 2021 Sep; 14(5):555-567. PubMed ID: 33491116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
    Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
    Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-based care for the management of type 2 diabetes: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(23):1-40. PubMed ID: 23074528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker In Diabetes with Earlier Chronic Kidney Disease Stages.
    Bai Y; Yang R; Song Y; Wang Y
    Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):220-225. PubMed ID: 29270924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home telemonitoring for type 2 diabetes: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(24):1-38. PubMed ID: 23074529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on biomarkers of glycemic control.
    Krhač M; Lovrenčić MV
    World J Diabetes; 2019 Jan; 10(1):1-15. PubMed ID: 30697366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.